This invention relates to safe hypodermic needles wherein the needle is protected after injection to prevent medical practitioners from receiving needle stick injuries and infections.
The present invention is directed in general to a safe needle device for syringes as used in the medical industry and hospitals. The “Improvement patent” (classified as UTILITY patent, according to the USPTO) application presents significant improvements, which are based upon numerous marketability tests (see Commercial Feasibility after the Background section below) conducted over the past several years and after FDA 510(k) approval to market the invention, issued under K010477. The improvements are:
With the advent of AIDS and other highly infectious diseases, syringes and scalpels and other sharps devices have caused numerous injuries and infections to administering medical staff. Protective devices have been introduced to the market after the U.S. legislation in 1998, but consisted of needle covers that still left part of the needle exposed after use and thereby subjecting the clinician to exposure to contaminated blood.
These devices are still on the market, but are not user friendly and safe. For example, a nurse must use two hands to prepare a patient for an injection. One hand is used to clean the area to be injected with a disinfectant while the other hand is used to inject the needle into the tissue. After removing the needle from the patient, the administering nurse must press on the spot of injection and hold the syringe in the other hand. After pressing the spot is complete (to stop the flow of blood), the nurse, in prior protective devices, then uses that hand to twist a cover over the syringe or sharp. That requires two hands during which time the needle may drip blood on the patient or the nurse where contamination is inevitable. In addition, the maneuvering to accomplish the foregoing may cause an inadvertent puncturing of the nurse's own skin, thus inviting infection. One such device is Badger U.S. Pat. No. 5,885,257, which is a very cumbersome releasable retaining device to retract the needle where it will not cause harm.
In 2012 the WHO (World Health Organization) in Geneva, Switzerland, published a decree saying that all countries must implement the use of RETRACTABLE safety syringes by the year 2020. That means conventional needle covers, which don't provide the needed protection, will no longer be acceptable or allowed.
In this Improvement patent filing the above statements remain unchanged, but the ease of handling during administering medication by a clinician is greatly improved and so is increased safety to the patient and clinician. Two mechanically retracting safety syringes came on the market, i.e. the Integra, marketed by BD (Becton Dickenson) of Franklin, N.J., U.S. Pat. No. 5,632,733 (Shaw) and U.S. Pat. No. 7,351,224 (Shaw) and the Vanish Point, marketed by RTI (Retractable Technology, Inc.) of Houston, Tex., U.S. Pat. No. 6,090,077 (Shaw, 7/2000). While the spring-operated needle retraction is the same in both devices (BD and RTI) they both have their compression springs located in the front end of the syringe whereas the present invention has the spring located inside the plunger. In addition, the Vanish Point does not have a Luer-Lock and, thus, does not permit interchangeability of needles prior to use. The Integra is hard to push to cause retraction which is a detriment for single hand operation because it can cause significant patient discomfort especially when the device is triggered while the needle is still in the patient, The spring assembly in the Integra (BD) can easily be removed after retraction; it falls apart. The 3 patents cited above, I.e. U.S. Pat. No. 5,632,733, U.S. Pat. No. 7,351,224 and U.S. Pat. No. 6,090,077, issued to Shaw 9 years after Botich FIGS. 1-5, are identical in their basic construction and function to Botich, FIGS. 1-5. They all use what is referred to in the industry as “front retraction”, meaning that the spring is at the distal end of the syringe and is part of the needle base.
In contrast to Botich, FIGS. 1-5 and the Shaw inventions, Botich shows in FIG. 6 a rear retraction syringe where the needle retraction is activated from the proximal end of the syringe (see U.S. Pat. No. 4,994,034 FIG. 6, Botich (1991). There are many differences between Botich and the current invention. For example, Botich teaches the retraction of an injection needle via a spring inside a spring housing that is pushed into the hollow cavity of a syringe plunger that does not have a conventional rubber seal. Although similar, Botich achieves this by different means. Specifically, (claim 15 (b), lines 27-42), Botich states that the use of a “cylindrical spring housing . . . wherein a spring is retained, . . . having exteriorly located attachment tabs . . . ” retraction is accomplished.
The syringe housing is “ . . . held by said syringe barrel . . . ” (claim 16 (d), col. 14, lines 7-8). In contrast, the instant invention does not use a spring housing. Instead, the spring is retained against a collar inside the plunger without the need for holding means against the barrel, which, when combined with Botich's claim 15 (d), col. 12, lines 58-62, stating “ . . . sealing means to provide an air tight seal between said exterior of said cylindrical spring housing and said interior of said barrel . . . ”, creates excessive friction during aspiration of medication making one-hand operation very difficult, if not impossible.
Botich, furthermore, teaches that his spring housing, i.e. the needle retractor housing, upon “Further downward pressure on the plunger 59 forces the needle retractor housing 115 past detents 117 . . . ” (col. 9, lines 48-50), which (detents) by the way, are located outside the plunger on the inner wall of the syringe barrel, as mentioned before. This means that Botich's needle retractor housing, after it passes the external (to the plunger) detents 117 “ . . . is moved deeper into the cylindrical cavity 71 of the plunger 59.” (col. 9, lines 54-56). Botich does not explain how his needle retractor housing with external hooks on the plunger, that engage with detents 117, can “move deeper into the cylindrical cavity 71 of the plunger 59”. That restriction requires “ . . . an extra piston spacer 123” (col. 9, line 57). None of these constraints and requirements “ . . . for proper operation . . . ” (col. 9, line 57) exist in the instant invention. In claim 2 Botich states “ . . . said frangible end of said syringe plunger separates (to allow retraction) when a “ . . . force is exerted . . . ” (col. 10, lines 56-57). In other words without the break-off/separation, there is no retraction. No such separation takes place in the present invention, which assures retraction everytime because of an entirely different and superior receiver assembly design.
In claim 5 Botich states “ . . . wherein said interior cavity of said syringe plunger is evacuated prior to the separation of said frangible end . . . ” (col. 11, lines 5-6). The present invention does not require evacuation—which Botich needs to suck up spilled blood—; it is free of any blood to be spilled, which is a prerequisite of any needle safety device as mandated by the FDA/CDC. Botich could not meet today's requirements with his inferior design. The present invention meets all requirements of the FDA.
Furthermore, the distal end of Botich's needle retention housing is not conducive to reducing dead pace because of a mismatch in surfaces. The present invention addresses this aspect specifically by means of mating surfaces. Finally, Botich describes in claim 15 (d), col. 12, line 53 that the syringe barrel is “ . . . engaging and holding said cylindrical spring housing . . . ” by means of “ . . . slots and a groove . . . ” (col. 12, line 55) inside the barrel. The present invention does not require or use a spring housing and, consequently, does not require slots and a groove in the barrel.
In U.S. Pat. No. 5,053,010, McGary states in claim 1. “ . . . a cutting tip configured inside said sealing member . . . ” in claim 2 he states “ . . . said cutting tip is a beveled knife”.
The current invention does not use any cutting tip. It uses a mechanically interlocking tip-lock. In U.S. Pat. No. 5,211,629, Pressly (10/1991) states “Positioned between sacrificial supports in the needle assembly and the barrel is a deformable base and . . . the plunger has a rupturable boot”. The McGary and Pressly inventions are quite a departure from the Grabis invention.
After extensive marketability testing and commercial feasibility evaluation, the present invention was made faster in retraction, smaller in the outer diameter, lighter and cheaper to manufacture.
A self-retracting safety syringe has a hollow syringe body, a hollow needle having a point at its tip and a tip-lock at its base, a sleeve around the needle configured to sealingly retain the needle, a hollow plunger configured to engage the interior wall of the syringe body, the plunger having a tip sealingly engaged with the interior wall and having an aperture therein to accommodate the tip-lock, a collar circumferentially mounted on the interior wall of the plunger, a retractor for accepting and retaining the tip-lock, wherein the distal end is retained within the proximal end of the plunger by the collar, and a spring biasing the retractor against the collar, wherein the tip-lock and plunger join, and wherein the retractor is pushed past the collar and is adapted to pull the needle from within the sleeve into the hollow plunger.
In an embodiment, the sleeve has a Luer-Lock connection at the distal end of the syringe body to sealingly retain the needle against the syringe body.
The foregoing and other features and advantages of the invention will be apparent from the following, more particular description of the preferred embodiments of the invention, the accompanying drawings, and the claims.
For a more complete understanding of the present invention, the objects and advantages thereof, reference is now made to the ensuing descriptions taken in connection with the accompanying drawings briefly described as follows.
Preferred embodiments of the present invention and their advantages may be understood by referring to
It is a general object of the improvements to the original invention, as shown in patent U.S. Pat. No. 6,322,540 B1 to provide a further improved retractable safety needle device for syringes.
In accordance with the above object, there is provided a needle-stick safety syringe comprising a tubular body, cylindrical plunger, and an extended needle at the distal end of the tubular body. Said needle to be removable, through attachment means, such as a Luer-Lock connector, in order to be replaced with a different size needle if so desired or required based upon patient needs or with a blunt fill needle or tubing with matching connectors.
Referring now to
The needle and sleeve are mounted within the female connector 8.
The compression spring 22 is positioned inside said plunger 1 between a collar 19 and an Inward lip (
The tip-lock 20 engages with the plunger 1 and locks to the plunger tip, through the rubber seal 66 and the spring 22 to the receiver assembly 23 and 29 inside the plunger 1. The plunger tip and needle base assembly (
The spring 22 serves to retract the needle 4 when activated by the tip-lock 20, which pushes the receiver assembly 23 and 29 through a friction collar 28 after the tip-lock 20 is connected to the tip of the plunger 1. The spring 22 is compressed between the tip of plunger 1 and a collar 19 within the plunger 1 so that the spring 22 can not slide over it while compressed. As the spring 22 uncoils it pushes said receiver assembly 23 and 29 and the locked tip-lock 20, with needle 4 attached to it, to the proximal end of the plunger 1. The wedged pressure-fitted collar 28, being positioned on the inside wall of the plunger 1, permits the tip-lock 20 to push the collar 19, which is part of the receiver assembly 23 and 29, through it, by applying thumb pressure to the end of the plunger 1 so that the spring 22 can uncoil and pull the receiver assembly 23 and 29 with its connected needle 4 with sleeve 7 out of the needle base assembly (
As
With reference to
With further reference to
In use, as the plunger 60 descends, the rubber seal 66, attached to the distal end 62 of the plunger 60, sealingly pressurizes liquids within the cylinder 75 such that they are expelled out the needle 52, typically into a patient. The needle 52 has a channel therein to permit the passage of fluids therethrough. The tip-lock 56 is mounted on supports 77 to permit fluid to flow through the rubber seal 66, which has an aperture therein (center hole not shown) to permit access to the retractor 70. As the plunger 60 is depressed, the tip-lock 56 enters the retractor 70 and is locked therein. At the distal end, the retractor 70 has a receiver adapted to receive and retain the tip-lock 56, and a stop to prevent the tip-lock 56 from moving through the retractor 70. As the plunger 60 is further depressed, the tip-lock 56 passes the retractor 70 opening through the rubber seal 66 and the center of the spring 72 and engages with the receiver inside the plunger 60. The force causes the distal end of the retractor 70 to push against the collar, and move past the collar to enter the proximal end of the interior of the plunger 60. As the retractor 70 is spring biased into the distal end of the plunger 60, it moves with some rapidity into the end, pulling the tip-lock 56, and consequently the needle 52, along with it into the body of the plunger 60.
The invention has been described herein using specific embodiments for the purposes of illustration only. It will be readily apparent to one of ordinary skill in the art, however, that the principles of the invention can be embodied in other ways. Therefore, the invention should not be regarded limited in scope to the specific embodiments disclosed herein, but instead as being fully commensurate in scope with the following claims:
The present application is a continuation in part of U.S. Ser. No. 14/853,158 filed on Sep. 9, 2015 and of U.S. Ser. No. 13/723,258 filed on Dec. 21, 2012 entitled “Safe Needle Device for Syringes” the entire disclosure of which is incorporated by reference herein.